The LMC wrote to ABUHB with concerns that a review was needed with regard to recent anticoagulation developments, which include Nice AF Guidance, the recent transmission locally of TTR and the green light approval for use of Rivaroxaban in primary care in Gwent.

In response, LMC and ABUHB have set up a task and finish group to work for consideration of the service approach needed to tackle various aspects of anticoagulation. This will include consideration of the current anticoagulation ES, in addition the slow loading of warfarin, introduction of NOACs and the funding of any initiatives. This is going to be a priority to be completed as soon as possible.

The issue of TTR read-coding has been raised and a solution is being sought.